Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2006-11-30
pubmed:abstractText
Controlled studies established the efficacy and good tolerability of pimecrolimus cream 1% for the treatment of atopic dermatitis but they may not reflect real-life use.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1018-8665
pubmed:author
pubmed:copyrightInfo
Copyright (c) 2006 S. Karger AG, Basel.
pubmed:issnType
Print
pubmed:volume
213
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
313-8
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:17135737-Administration, Cutaneous, pubmed-meshheading:17135737-Adolescent, pubmed-meshheading:17135737-Adult, pubmed-meshheading:17135737-Aged, pubmed-meshheading:17135737-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:17135737-Calcineurin, pubmed-meshheading:17135737-Child, pubmed-meshheading:17135737-Child, Preschool, pubmed-meshheading:17135737-Cohort Studies, pubmed-meshheading:17135737-Dermatitis, Atopic, pubmed-meshheading:17135737-Facial Dermatoses, pubmed-meshheading:17135737-Female, pubmed-meshheading:17135737-Follow-Up Studies, pubmed-meshheading:17135737-Humans, pubmed-meshheading:17135737-Infant, pubmed-meshheading:17135737-Male, pubmed-meshheading:17135737-Middle Aged, pubmed-meshheading:17135737-Ointments, pubmed-meshheading:17135737-Patient Satisfaction, pubmed-meshheading:17135737-Peptidylprolyl Isomerase, pubmed-meshheading:17135737-Safety, pubmed-meshheading:17135737-Tacrolimus, pubmed-meshheading:17135737-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohort.
pubmed:affiliation
Department of Dermatology, University Hospital Bern, Bern, Switzerland. dagmar.simon@insel.ch
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, Non-U.S. Gov't, Multicenter Study